Sinomenine Hydrochloride Can Ameliorate Benign Prostatic Hyperplasia by Lowering the 5α-Reductase 2 Level and Regulating the Balance between the Proliferation and Apoptosis of Cells
-
Published:2023-01-13
Issue:2
Volume:28
Page:803
-
ISSN:1420-3049
-
Container-title:Molecules
-
language:en
-
Short-container-title:Molecules
Author:
Fan Mao-Si,Xia Yue-Fei,Ye Rui-Han,Sun Ze-Rui,Wang Ming-Yue,An Meng-Fei,Zhang Shao-Shi,Zhang Li-Juan,Zhao Yun-Li,Xiang Ze-Min,Sheng Jun
Abstract
Benign prostatic hyperplasia (BPH) is a chronic disease that affects the quality of life of older males. Sinomenine hydrochloride (SIN) is the major bioactive alkaloid isolated from the roots of the traditional Chinese medicinal plant Sinomenium acutum Rehderett Wilson. We wondered if the SIN administration exerted a regulatory effect on BPH and its potential mechanism of action. Mice with testosterone propionate-induced BPH subjected to bilateral orchiectomy were employed for in vivo experiments. A human BPH cell line (BPH-1) was employed for in vitro experiments. SIN administration inhibited the proliferation of BPH-1 cells (p < 0.05) by regulating the expression of androgen-related proteins (steroid 5-alpha reductase 2 (SRD5A2), androgen receptors, prostate-specific antigen), apoptosis-related proteins (B-cell lymphoma 2 (Bcl-2), Bcl-2-associated X protein (Bax)) and proliferation-related proteins (proliferating cell nuclear antigen (PCNA), mammalian target of rapamycin, inducible nitric oxide synthase) in vitro. SIN administration decreased the prostate-gland weight coefficient (p < 0.05) and improved the histological status of mice suffering from BPH. The regulatory effects of SIN administration on SRD5A2, an apoptosis-related protein (Bcl-2), and proliferation-related proteins (PCNA, matrix metalloproteinase-2) were consistent with in vitro data. SIN exerted a therapeutic effect against BPH probably related to lowering the SRD5A2 level and regulating the balance between the proliferation and apoptosis of cells. Our results provide an important theoretical basis for the development of plant medicines for BPH therapy.
Funder
National Natural Science Foundation of China
Yunnan Provincial Science and Technology Project
Yunnan provincial key programs of Yunnan Eco-friendly Food International Cooperation Research Center project
Subject
Chemistry (miscellaneous),Analytical Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Molecular Medicine,Drug Discovery,Pharmaceutical Science
Reference30 articles.
1. What is a disease? What is the disease clinical benign prostatic hyperplasia (BPH)?;Foo;World J. Urol.,2019
2. Benign prostatic hyperplasia—What do we know?;Devlin;BJU Int.,2021
3. Baicalin alleviates benign prostate hyperplasia through androgen-dependent apoptosis;Jin;Aging,2020
4. Medical therapy for benign prostatic hyperplasia: A review;Barkin;Can. J. Urol.,2015
5. Evidence for atrophy and apoptosis in the prostates of men given finasteride;Rittmaster;J. Clin. Endocrinol. Metab.,1996
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献